Finance

Lists
Why is 300562 down 2,46%?
Dive Deeper
300562:SHE
Guangdong Transtek Medicl Elctrncs CoLtd
13,08 CNY
-2,46%
(-0,33) 1D
16 ოქტ, 15:04:58 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300562...
Open
13,67 CNY
High
13,77 CNY
Low
12,94 CNY
Mkt. cap
3,15 მლრდ.
Avg. vol.
16,51 მლნ.
Volume
8,14 მლნ.
Dividend
1,99%
Quarterly dividend
0,07 CNY
Ex-dividend date
15 ოქტ. 2026
P/E ratio
28,64
52-wk high
19,54 CNY
52-wk low
11,32 CNY
EPS
0,46 CNY
Shares outstanding
218,93 მლნ.
No. of employees
1 ათ.
Open
13,67 CNY
High
13,77 CNY
Low
12,94 CNY
Mkt. cap
3,15 მლრდ.
Avg. vol.
16,51 მლნ.
Volume
8,14 მლნ.
Dividend
1,99%
Quarterly dividend
0,07 CNY
Ex-dividend date
15 ოქტ. 2026
P/E ratio
28,64
52-wk high
19,54 CNY
52-wk low
11,32 CNY
EPS
0,46 CNY
Shares outstanding
218,93 მლნ.
No. of employees
1 ათ.
News stories
From web sources and news partners
Profile
Transtek Medical, commonly known as Lifesense, fully referred to as Guangdong Transtek Medical Electronics Co., Ltd., is a Chinese wearable device maker that also focuses on the field of mobile health. The company was founded by Weichao Pan in 2002, with its main products being home medical and health electronics, such as scales, smart bracelets and blood pressure monitors. According to IDC, the company shipped one million units of wearables in the second quarter of 2016, ranking fifth in the global wearable devices market, coming in behind Fitbit, Apple and Garmin. Transtek's IPO application was approved by the CSRC in October 2016. On November 16, it landed on the Shenzhen Stock Exchange with the ticker symbol "300562.SZ". Wikipedia
About Guangdong Transtek Medicl Elctrncs CoLtd
CEO-
Employees1,09 ათ.
Founded18 ივლ. 2002
Headquarters-
SectorMedical device
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
235,76 მლნ.
229,08 მლნ.
283,74 მლნ.
250,69 მლნ.
Cost of goods sold
149,14 მლნ.
152,94 მლნ.
176,58 მლნ.
166,11 მლნ.
Cost of revenue
149,14 მლნ.
152,94 მლნ.
176,58 მლნ.
166,11 მლნ.
Research and development expenses
20,36 მლნ.
24,79 მლნ.
26,69 მლნ.
23,33 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
41,57 მლნ.
26,45 მლნ.
41,12 მლნ.
21,85 მლნ.
Operating expense
58,96 მლნ.
52,61 მლნ.
71,19 მლნ.
48,25 მლნ.
Total operating expenses
208,10 მლნ.
205,55 მლნ.
247,78 მლნ.
214,35 მლნ.
Operating income
27,66 მლნ.
23,53 მლნ.
35,96 მლნ.
36,34 მლნ.
Other non operating income
-3,39 მლნ.
2,22 მლნ.
-4,58 მლნ.
3,96 მლნ.
EBT including unusual items
23,63 მლნ.
16,59 მლნ.
32,82 მლნ.
31,28 მლნ.
EBT excluding unusual items
25,70 მლნ.
24,73 მლნ.
31,68 მლნ.
34,21 მლნ.
Income tax expense
118,51 ათ.
1,08 მლნ.
931,10 ათ.
3,84 მლნ.
Effective tax rate
0,50%
6,54%
2,84%
12,27%
Other operating expenses
-1,92 მლნ.
3,87 მლნ.
1,19 მლნ.
2,80 მლნ.
Net income
23,39 მლნ.
16,32 მლნ.
32,07 მლნ.
27,96 მლნ.
Net profit margin
9,92%
7,12%
11,30%
11,15%
Earnings per share
-
-
-
-
Interest and investment income
3,39 მლნ.
2,85 მლნ.
330,33 ათ.
3,10 მლნ.
Interest expense
-1,40 მლნ.
-
-37,02 ათ.
-57,71 ათ.
Net interest expenses
1,99 მლნ.
2,85 მლნ.
293,32 ათ.
3,05 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
32,45 მლნ.
28,29 მლნ.
40,73 მლნ.
41,00 მლნ.
Gain or loss from assets sale
-150,13 ათ.
26,11 ათ.
-
-1,36 მლნ.
AI content may include mistakes. Learn more
Google აპები